Iwaki M, Kessoku T, Kanamori T, et al. Tapentadol Safety and Patient Characteristics Associated with Treatment Discontinuation in Cancer Therapy: A Retrospective Multicentre Study in Japan [published online ahead of print, 2021 Sep 28]. Pain Ther. 2021;10.1007/s40122-021-00327-z. doi:10.1007/s40122-021-00327-z

Ahsan MZ, Zhao MJ, Shoaib RM, Zhang Y, Wang YX. Comparative study of dezocine, pentazocine and tapentadol on antinociception and physical dependence. Life Sci. 2021;285:119996. doi:10.1016/j.lfs.2021.119996

Seralathan M, Singh GK, Huddar S, Mathew L, Kandasamy A, Mahadevan J. Intravenous tapentadol use related seizures – A Case Report. Asian J Psychiatr. 2021;66:102911. doi:10.1016/j.ajp.2021.102911

Pujol J, Martínez-Vilavella G, Doreste A, et al. Tapentadol effects on brain response to pain in sensitized patients with knee osteoarthritis [published online ahead of print, 2021 Oct 12]. Rheumatology (Oxford). 2021;keab761. doi:10.1093/rheumatology/keab761

Viñas-Bastart M, Oms-Arias M, Pedraza-Gutiérrez À, Lizano-Díez I, Mariño EL, Modamio P. Tapentadol and Oxycodone/Naloxone Prescribing Patterns in Primary Health Care in Catalonia, Spain: A Cross-Sectional Study. Risk Manag Healthc Policy. 2021;14:4155-4168. Published 2021 Oct 4. doi:10.2147/RMHP.S301724

Nedergaard RB, Hansen TM, Nissen TD, Mark EB, Brock C, Drewes AM. The effects of tapentadol and oxycodone on central processing of tonic pain. Clin Neurophysiol. 2021;132(10):2342-2350. doi:10.1016/j.clinph.2021.07.021

Wang X, Penm J, Patanwala AE. Cost-effectiveness of tapentadol immediate release versus oxycodone immediate release for acute post-operative pain after major hip surgeries [published online ahead of print, 2021 Oct 23]. Curr Med Res Opin. 2021;1-7. doi:10.1080/03007995.2021.1993161

Ruggeri M, Signorini A, Caravaggio S, Santori C, Rosiello F, Coluzzi F. Cost-Effectiveness Analysis of Tapentadol Versus Oxycodone/Naloxone in both Branded and Generic Formulations in Patients with Musculoskeletal Pain. Clin Drug Investig. 2021;41(10):875-883. doi:10.1007/s40261-021-01074-x

Webster L, Rauck RL. Atypical opioids and their effect on respiratory drive. J Opioid Manag. 2021;17(7):109-118. doi:10.5055/jom.2021.0648

Takemura M, Niki K, Okamoto Y, et al. Tapentadol in Cancer Patients with Neuropathic Pain: A Comparison of Methadone, Oxycodone, Fentanyl, and Hydromorphone. Biol Pharm Bull. 2021;44(9):1286-1293. doi:10.1248/bpb.b21-00212